<DOC>
	<DOCNO>NCT01662518</DOCNO>
	<brief_summary>This study evaluate safety efficacy intravitreal implant dexamethasone ( DDS-25 ) treatment macular edema associate retinal vein occlusion .</brief_summary>
	<brief_title>DDS-25 Gauge Patients With Macular Edema Secondary Retinal Vein Occlusion ( RVO )</brief_title>
	<detailed_description>Evaluate effect visual acuity , electroretinography , fluorescein angiography optical coherence tomography 10 patient macular edema associate retinal vein occlusion undergo intravitreal injection implant dexamethasone ( DDS-25 ) .</detailed_description>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Retinal Vein Occlusion</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>18 year age old macular edema result retinal vein occlusion Decrease visual acuity least one eye result macular edema ( 20/50 worse ) Visual acuity eye worse 20/200 Known anticipate need ocular surgery within next 12 month History glaucoma current high eye pressure require 1 medication Diabetic retinopathy Uncontrolled systemic disease Known steroidresponder Use systemic steroid Use warfarin/heparin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>